Attenuation	attenuation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
lithium-induced	lithium-induced	O	O	O	O
diabetes-insipidus-like	diabetes-insipidus-like	O	O	O	O
syndrome	syndrome	O	O	O	O
by	by	O	O	O	O
amiloride	amiloride	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
amiloride	amiloride	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
lithium-induced	lithium-induced	O	O	O	O
polydipsia	polydipsia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
polyuria	polyuria	O	DISEASE	OTHERS	I
and	and	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
plasma	plasma	O	O	O	O
,	,	O	O	O	O
brain	brain	O	O	O	O
,	,	O	O	O	O
kidney	kidney	O	O	O	O
,	,	O	O	O	O
thyroid	thyroid	O	O	O	O
and	and	O	O	O	O
red	red	O	O	O	O
blood	blood	O	O	O	O
cells	cells	O	O	O	O
was	was	O	O	O	O
investigated	investigated	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
chronically	chronically	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
LiCl	licl	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Amiloride	amiloride	CHEMICALS	O	OTHERS	I
reduced	reduced	O	O	O	O
the	the	O	O	O	O
drinking	drinking	O	O	O	O
and	and	O	O	O	O
urine	urine	O	O	O	O
volume	volume	O	O	O	O
of	of	O	O	O	O
rats	rats	O	O	O	O
in	in	O	O	O	O
an	an	O	O	O	O
acute	acute	O	O	O	O
(	(	O	O	O	O
6	6	O	O	O	O
or	or	O	O	O	O
12	12	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
subacute	subacute	O	O	O	O
(	(	O	O	O	O
3	3	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
experiment	experiment	O	O	O	O
.	.	O	O	O	O

6	6	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
amiloride	amiloride	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
reduction	reduction	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
content	content	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
renal	renal	O	O	O	O
medulla	medulla	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
organs	organs	O	O	O	O
studied	studied	O	O	O	O
.	.	O	O	O	O

At	at	O	O	O	O
12	12	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
all	all	O	O	O	O
the	the	O	O	O	O
tissues	tissues	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
slight	slight	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
3	3	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
combined	combined	O	O	O	O
treatment	treatment	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
marked	marked	O	O	O	O
elevation	elevation	O	O	O	O
in	in	O	O	O	O
plasma	plasma	O	O	O	O
and	and	O	O	O	O
tissue	tissue	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
accompanied	accompanied	O	O	O	O
a	a	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
water	water	O	O	O	O
intake	intake	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
all	all	O	O	O	O
the	the	O	O	O	O
experiments	experiments	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
attenuation	attenuation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
lithium-induced	lithium-induced	O	O	O	O
diabetes-insipidus-like	diabetes-insipidus-like	O	O	O	O
syndrome	syndrome	O	O	O	O
by	by	O	O	O	O
amiloride	amiloride	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
accompanied	accompanied	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
reduction	reduction	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
ratio	ratio	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
renal	renal	O	O	O	O
medulla	medulla	O	O	O	O
and	and	O	O	O	O
its	its	O	O	O	O
levels	levels	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
blood	blood	O	O	O	O
and	and	O	O	O	O
an	an	O	O	O	O
elevation	elevation	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
plasma	plasma	O	O	O	O
potassium	potassium	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
acute	acute	O	O	O	O
amiloride	amiloride	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
to	to	O	O	O	O
lithium-treated	lithium-treated	O	O	O	O
patients	patients	O	O	O	O
suffering	suffering	O	O	O	O
from	from	O	O	O	O
polydipsia	polydipsia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
polyuria	polyuria	O	DISEASE	OTHERS	I
might	might	O	O	O	O
relieve	relieve	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
but	but	O	O	O	O
prolonged	prolonged	O	O	O	O
amiloride	amiloride	CHEMICALS	O	OTHERS	I
supplementation	supplementation	O	O	O	O
would	would	O	O	O	O
result	result	O	O	O	O
in	in	O	O	O	O
elevated	elevated	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
and	and	O	O	O	O
might	might	O	O	O	O
be	be	O	O	O	O
hazardous	hazardous	O	O	O	O
.	.	O	O	O	O

